Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devalingam Mahalingam

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012
Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumorsLee S Rosen, Igor Puzanov, Gregory Friberg, et al.
Cancer|January 3, 2025
A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancersDevalingam Mahalingam, Taofeek K Owonikoko, Ebrahim Delpassand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2020
Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract CancerLipika Goyal, Cynthia Sirard, Michael Schrag, et al.
Cancer Research|May 28, 2021
Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate CancerPawel A Osmulski, Alessandra Cunsolo, Meizhen Chen, et al.
JCO Precision Oncology|June 30, 2022
Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's ExperienceLorenzo Gerratana, Michael Movarek, Firas Wehbe, et al.
Cardiovascular and Interventional Radiology|March 3, 2019
Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
Cardiovascular and Interventional Radiology|February 8, 2020
Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid TumorsJohn Sarantopoulos, Geoffrey I Shapiro, Roger B Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2014
A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumorsJordi Rodon, Hussein A Tawbi, Anne L Thomas, et al.
Clinical Lung Cancer|January 19, 2025
Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket TrialJonathan W Goldman, Alejandro Martinez Bueno, Christophe Dooms, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 19, 2012
Safety and pharmacokinetics of ganitumab (AMG 479) combined with sorafenib, panitumumab, erlotinib, or gemcitabine in patients with advanced solid tumorsLee S Rosen, Igor Puzanov, Gregory Friberg, et al.
Cancer|January 3, 2025
A trial of radiolabeled antibody yttrium-90-FF-21101 for the treatment of advanced ovarian and other cancersDevalingam Mahalingam, Taofeek K Owonikoko, Ebrahim Delpassand, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 4, 2020
Phase I and Biomarker Study of the Wnt Pathway Modulator DKN-01 in Combination with Gemcitabine/Cisplatin in Advanced Biliary Tract CancerLipika Goyal, Cynthia Sirard, Michael Schrag, et al.
Cancer Research|May 28, 2021
Contacts with Macrophages Promote an Aggressive Nanomechanical Phenotype of Circulating Tumor Cells in Prostate CancerPawel A Osmulski, Alessandra Cunsolo, Meizhen Chen, et al.
JCO Precision Oncology|June 30, 2022
Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's ExperienceLorenzo Gerratana, Michael Movarek, Firas Wehbe, et al.
Cardiovascular and Interventional Radiology|March 3, 2019
Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
Cardiovascular and Interventional Radiology|February 8, 2020
Correction to: Prognosticating Survival in Hepatocellular Carcinoma with Elevated Baseline Alpha-fetoprotein Treated with Radioembolization Using a Novel Laboratory Scoring System: Initial Development and ValidationRehan Ali, Yihe Yang, Mark Antkowiak, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 2, 2015
Phase I Study of the Investigational NEDD8-Activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients with Advanced Solid TumorsJohn Sarantopoulos, Geoffrey I Shapiro, Roger B Cohen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 14, 2014
A phase I, multicenter, open-label, first-in-human, dose-escalation study of the oral smoothened inhibitor Sonidegib (LDE225) in patients with advanced solid tumorsJordi Rodon, Hussein A Tawbi, Anne L Thomas, et al.
Clinical Lung Cancer|January 19, 2025
Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket TrialJonathan W Goldman, Alejandro Martinez Bueno, Christophe Dooms, et al.
Pageof 11